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ORIGINAL ARTICLE
The impact of seasonal operating room  
closures on wait times for oral cancer surgery
N. Mundi md,* J. Theurer PhD,* A. Warner MSc,† J. Yoo md,*† K. Fung md,*† D. MacNeil md MSc,*†  
S. Dhaliwal md,* E. Winquist md MSc,† D.A. Palma md PhD,† and A.C. Nichols md*†
ABSTRACT
Background Operating room slowdowns occur at specific intervals in the year as a cost-saving measure. We aim to 
investigate the impact of these slowdowns on the care of oral cavity cancer patients at a Canadian tertiary care centre.
Methods A total of 585 oral cavity cancer patients seen between 1999 and 2015 at the London Health Science 
Centre (lhsc) Head and Neck Multidisciplinary Clinic were included in this study. Operating room hours and 
patient load from 2006 to 2014 were calculated. Our primary endpoint was the wait time from consultation to 
definitive surgery. Exposure variables were defined according to wait time intervals occurring during time periods 
with reduced operating room hours.
Results Overall case volume rose significantly from 2006 to 2014 (p < 0.001), while operating room hours remained 
stable (p = 0.555). Patient wait times for surgery increased from 16.3 days prior to 2003 to 25.5 days in 2015 (p = 0.008). 
Significant variability in operating room hours was observed by month, with lowest reported for July and August 
(p = 0.002). The greater the exposure to these months, the more likely patients were to wait longer than 28 days 
for surgery (odds ratio per day [or]: 1.07, 95% confidence interval [ci]: 1.05 to 1.10, p < 0.001). Individuals seen in 
consultation preceding a month with below average operating room hours had a higher risk of disease recurrence 
and/or death (hazard ratio [hr]: 1.59, 95% ci: 1.10 to 2.30, p = 0.014).
Conclusions Scheduled reductions in available operating room hours contribute to prolonged wait times and higher 
disease recurrence. Further work is needed to identify strategies maximizing efficient use of health care resources 
without negatively affecting patient outcomes.
Key Words Oral cancer, wait times, resources
Curr Oncol. 2018 Feb;25(1):67-72 www.current-oncology.com
INTRODUCTION
Head and neck cancer (hnc) has not gained the public 
awareness of other more common adult solid tumours, 
yet it remains a formidable public health problem. It is 
the fifth most common cancer worldwide, accounting for 
approximately 500,000 cases per annum, and 4,500 cases 
in Canada1-3. Unfortunately, both the disease process and 
current treatment strategies can have a profound negative 
impact on patient quality of life, due to difficulty eating and 
speaking, as well as possible disfigurement. Survival rates 
for hnc continue to be poor, with fewer than 50% of patients 
with advanced disease alive at five years4. 
Across Canada, wait times for cancer diagnosis and 
treatment remain an obstacle to optimal patient care. 
Previous studies have demonstrated that surgical wait 
times may influence survival outcomes in uterine and 
bladder cancers, respectively5,6. A landmark investiga-
tion by Van Harten et al.7 in the Netherlands showed that 
longer wait times for head and neck cancer surgery were 
associated with a higher risk of death; the hazard of dying 
increased by 7% for each week waited for treatment. Longer 
wait times for cancer surgery put patients not only at risk of 
increased morbidity due to larger resections secondary to 
tumour progression7, but also at increased risk of mortality. 
Thus, strategies to ensure prompt treatment are crucial to 
obtain optimal patient outcomes.
In Canada, frequently cited barriers to timely hnc care 
include delay in referrals from primary care physicians to 
community otolaryngologists and, subsequently, delays 
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in referral from these specialists to head and neck surgical 
oncologists. However, another barrier often cited has been 
lack of operating room time8. Cancer Care Ontario (cco) 
guidelines for hnc treatment include a target wait time of 
28 days from specialist consult to treatment for surgery. 
Despite this, cco has reported that only 83% of hnc patients 
receive treatment within this time frame9. Data from the 
Maritime provinces has revealed even longer wait times10, 
suggesting that this may be a nationwide problem.
To reduce costs, many Canadian tertiary care centres 
reduce the operating room (or) hours available to surgeons 
during specific periods in the year, typically in the summer 
months and over the Christmas holidays. Despite this wide-
spread practice, there is a paucity of data studying the im-
pact of these slowdown periods on surgical wait times and 
patient outcomes. We examined these outcomes for oral 
cavity cancer patients at a large, tertiary-care institution.
METHODS
Patient Population
Of all oral cavity cancer patients seen in consultation between 
January 1999 and December 2015 at the London Health Sci-
ence Centre (lhsc) Head and Neck Cancer Multidisciplinary 
Clinic (hn mdt clinic) patients who met the following inclusion 
criteria were included in our analysis: diagnosis of a primary 
oral cavity squamous cell carcinoma, cancer treated with pri-
mary surgery with or without adjuvant therapy, surgery and 
adjuvant therapy provided at lhsc. Patients with inadequate 
electronic or paper records were excluded.
Patient demographic data (Table I), date of consultation, 
date of surgery, and date of adjuvant radiotherapy initiation 
were extracted by retrospective chart review. Operating 
room hours for all head and neck surgical oncologists were 
tabulated from Department of Otolaryngology – Head and 
Neck Surgery records for the same time period. In addition, 
we tabulated the total number of hnc patients referred to our 
Multidisciplinary Clinic between 2006 and 2014.
Statistical Analysis
The primary end point of interest was wait time from the 
date of consultation to the date of definitive surgery. Expo-
sure variables were defined according to wait time intervals 
occurring during time periods (or months) with reduced or 
hours. Each time period (or month) was classified accord-
ing to whether the total or hours was: (1) below the overall 
mean (“below mean”), (2) below the overall mean minus 
10% (“below mean – 10%”), and (3) during the summer 
months of July or August. Total or hours were examined 
over time and grouped by month to investigate seasonal 
trends. Trend tests were performed to test for increases in 
wait time over time using the linear trend test for wait time 
as a continuous variable. Multivariable logistic regression 
and Cox proportional hazards regression were performed 
to identify significant (p < 0.05) predictors of wait times > 
28 days and overall and progression-free survival, respec-
tively. All variables with available data for > 70% of patients 
(e.g., n > 410) were entered into a multivariable model 
and sequentially removed using backward elimination 
techniques until all remaining covariates had p < 0.10. For 
overall survival (os) and progression-free survival (pfs), 
wait time (as a continuous variable) was retained during 
all stages of model building in an effort to reduce bias. All 
statistical analysis was performed using SAS version 9.4 
(SAS institute, Cary, NC, U.S.A.), using two-sided statistical 
testing at the 0.05 significance level. 
RESULTS
Head and Neck Cancer Case Numbers and Surgical 
Oncology Time
The overall case volume rose dramatically, from 263 cases 
in 2006 to 419 cases in 2014, with an average increase of 16.4 
patients per year (p < 0.001) (Figure 1). Both the absolute 
number and the proportion of oral cavity cancer patients 
also increased significantly (p = 0.004 and p < 0.001, respec-
tively). Conversely, during this time period the number 
of or hours available to our surgeons remained stable 
(p = 0.555) (Figure 2).
Wait Times to Surgery and Adjuvant Radiotherapy
Between 1999 and 2015, patient wait times for surgery 
increased, from an average of 16.3 days prior to 2003 to 
TABLE I Baseline tumour, patient and treatment characteristics for 
all patients (n=585)
Characteristic N Patients
(n=585)
Age at Diagnosis –  
 mean ± SD, median (min, max)
585 62.8 ± 12.4
63.0 (22.0, 95.0)
Stage – n (%) 525
I 125 (23.8)
II 98 (18.7)
III 77 (14.7)
IV 225 (42.9)
T Stage – n (%) 585
T1 204 (34.9)
T2 183 (31.3)
T3 55 (9.4)
T4 143 (24.4)
N Stage – n (%) 585
N0 314 (53.7)
N1 78 (13.3)
N2 122 (20.9)
N3 6 (1.0)
NX 65 (11.1)
Location – n (%) 585
Tongue 276 (47.2)
Palate 23 (3.9)
Cheek/Buccal/Mucosa 63 (10.8)
Floor of Mouth 102 (17.4)
Mandible/Gingiva/Alveolus 94 (16.1)
Retromolar Trigone 27 (4.6)
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25.5 days in 2015 (p = 0.008) (Figure 3). Specifically, the 
percentage of patients waiting longer than four weeks (the 
cco guideline) significantly increased over this time frame 
(p = 0.006). Interestingly, during the same time period, we 
found that the mean patient wait time for adjuvant therapy 
decreased (p = 0.042) (Figure 4). 
Impact of OR Resources on Wait Times
Variability in or resources on a month-to-month basis 
was observed (Figure 5). This was found to be statistically 
significant (p = 0.002) and was largely due to fewer avail-
able or hours during the months of July and August (the 
traditional summertime “slowdown” months), followed 
thirdly by December (Figure 5).
Multivariable logistic regression analysis revealed that 
patients who had their initial surgical consultation in June 
immediately preceding the months of July and August had 
increased odds of waiting longer than 28 days for surgery 
(odds ratio: 3.07, 95% confidence interval: 1.96 to 4.81, p < 
0.001). Furthermore, each day of “exposure” a patient had 
to the summertime slowdown period of July and August 
caused an increased odds of prolonged wait times (odds 
ratio: 1.07, 95% confidence interval: 1.05 to 1.10, p < 0.001).
Impact of OR Resources on Patient Outcomes
Multivariable Cox proportional hazards regression 
analyses are shown in Table II. The analysis revealed that 
individuals who were seen in initial consultation preced-
ing a month with total or hours falling below the overall 
mean minus 10% had a significantly increased hazard of 
disease recurrence and/or death (hazard ratio: 1.59, 95% 
confidence interval: 1.10 to 2.30, p = 0.014).
FIGURE 1 Number of head and neck cancer consultations from 
2006 to 2014. Stacked bars represent the entire patient cohort per 
year, including number of oral cavity cases (light) and cases from all 
other sites (dark). 
FIGURE 2 Annual operating room hours available for head and neck 
surgical oncology at London Health Sciences Centre. OR = operating 
room. 
FIGURE 3 Wait time from consultation to operation. 
FIGURE 4 Wait times for post-operative radiation from date of surgery. 
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DISCUSSION
This large study, from a high-volume tertiary care centre, 
strongly suggests that patients who present for care before 
a month with reduced or hours experience long wait times 
and have a higher risk of disease recurrence. To our knowl-
edge, this is the first such study looking specifically at the 
holiday-related or slowdown periods.
Many system factors affect wait times for Canadian 
cancer patients, including lack of access to primary care, 
insufficient numbers of community and tertiary care spe-
cialists, and insufficient resources, particularly or time8. 
Canadian investigators have already reported that hnc 
patients are waiting longer than recommended for initial 
assessment and treatment10. Our report identifies excessive 
wait times for oral cavity cancer surgery that are increasing 
over time. This appears to be due to a rise in case numbers 
without an increase in available or hours. 
We identified that scheduled reductions in available or 
hours are a contributing factor to prolonged wait times. In 
an attempt to preserve healthcare resources by cutting or 
time for surgeons, the healthcare system may be putting 
patients at risk for poorer outcomes. These findings are 
consistent with those of Van Harten et al.7, who reported 
a causal relationship between delays to treatment and 
higher patient mortality in a similar patient population. 
We observed that individuals “exposed” to months with 
less than average or hours were at higher risk of cancer 
recurrence and trended toward higher mortality. We are 
in the process of opening a study to validate these findings 
with Canadian population-based data through the Institute 
for Clinical Evaluative Sciences (ices) program. If these 
findings hold true, they raise the following question: Is it 
ethical that patients diagnosed prior to or during planned 
or slowdowns receive suboptimal care? 
Finding an alternative to the traditional summertime 
or slowdown that occurs in many tertiary care centres 
nationwide might be a challenge. More dispersed, less 
drastic reductions in or hours spread over multiple 
months of the year may represent a solution to this issue. 
Doing so might mitigate the severe reduction in time 
available to surgeons seen during the summer months. 
Ideally, increased funding and better rationing of or 
hours are required.
On a positive note, the wait times for adjuvant radio-
therapy at our centre have declined over time. We believe 
this improvement may be attributable to coordinated im-
provements in pathology processing, radiation oncology 
consultation, and communication between caregivers. 
Efforts have been made to streamline surgical wait times 
by advocating for additional or resources and sharing cases 
among surgical oncologists to balance or waitlists. Despite 
these initiatives, wait times have only plateaued, which can 
be considered positively in view of increasing patient cases 
in a setting of fixed resources. We caution, however, that 
this maintenance of wait times may be at the expense of 
the treatment of less time-sensitive benign and malignant 
tumours such as salivary and thyroid tumours that head 
and neck surgeons often triage behind squamous cell can-
cer cases. This can potentially result in poorer outcomes for 
these patients, even if they are lower risk. Future research 
directions for our research group include examining wait 
times for all major histologies treated by our disease site to 
further understand the impact of increasing patient loads 
in the face of fixed resources.
CONCLUSIONS
Limitations of our study include its retrospective nature, 
the inclusion of only one hnc site, and study of a limited 
time period at one institution. We were limited to an eight-
year period as the site of hnc surgery in our city changed in 
2005; thus accurate or hour records could only be obtained 
for 2006 onward.
Our healthcare system is challenged by an aging popu-
lation and rising technology costs. While fiscal prudence 
is a necessity, our investigation suggests the possibility of 
harm due to seasonal or closures. Further work to iden-
tify strategies maximizing efficient use of health care 
resources without negatively affecting patient outcomes 
should continue.
CONFLICT OF INTEREST DISCLOSURES
We have read and understood Current Oncology’s policy on disclos-
ing conflicts of interest and declare that we have none.
AUTHOR AFFILIATIONS
*Department of Otolaryngology, London Health Sciences Centre, 
London, Ontario, Canada; †Department of Oncology, London 
Health Sciences Centre, London, Ontario, Canada.
REFERENCES
 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 
Global cancer statistics. Ca Cancer J Clin 2011;61(2):69.
 2. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. World-
wide trends in incidence rates for oral cavity and oropharyn-
geal cancers. J Clin Oncol 2013;31(36):4550.
FIGURE 5 Head and neck surgery available operating room time 
(2007–2015) plotted by month. OR = operating room.
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